Abstract:Nanoscale alteration of the molecular association between GABAB receptor and the CaV2.1 channel in actives zones the hippocampus of APP/PS1 mice. In wild‐type animals, the GABAB receptor and the CaV2.1 channel showed a high degree of co‐clustering in nanodomains (40 nm) of presynaptic active zones of axon terminals (at) establishing synapses with spines (s) of CA1 pyramidal cells. In APP/PS1 animals, the co‐clustering is lost, and molecules are detected at distances larger than 70 nm. Voltage‐gated CaV2.1 (P/Q‐type) Ca2+ channels play a crucial role in regulating neurotransmitter release, thus contributing to synaptic plasticity and to processes such as learning and memory. Despite their recognized importance in neural function, there is limited information on their potential involvement in neurodegenerative conditions such as Alzheimer's disease (AD). Here, we aimed to explore the impact of AD pathology on the density and nanoscale compartmentalization of CaV2.1 channels in the hippocampus in association with GABAB receptors. Histoblotting experiments showed that the density of CaV2.1 channel was significantly reduced in the hippocampus of APP/PS1 mice in a laminar‐dependent manner. CaV2.1 channel was enriched in the active zone of the axon terminals and was present at a very low density over the surface of dendritic tree of the CA1 pyramidal cells, as shown by quantitative SDS‐digested freeze‐fracture replica labelling (SDS‐FRL). In APP/PS1 mice, the density of CaV2.1 channel in the active zone was significantly reduced in the strata radiatum and lacunosum‐moleculare, while it remained unaltered in the stratum oriens. The decline in Cav2.1 channel density was found to be associated with a corresponding impairment in the GABAergic synaptic function, as evidenced by electrophysiological experiments carried out in the hippocampus of APP/PS1 mice. Remarkably, double SDS‐FRL showed a co‐clustering of CaV2.1 channel and GABAB1 receptor in nanodomains (~40–50 nm) in wild type mice, while in APP/PS1 mice this nanoarchitecture was absent. Together, these findings suggest that the AD pathology‐induced reduction in CaV2.1 channel density and CaV2.1‐GABAB1 de‐clustering may play a role in the synaptic transmission alterations shown in the AD hippocampus. Therefore, uncovering these layer‐dependent changes in P/Q calcium currents associated with AD pathology can benefit the development of future strategies for AD management.

Nanoscale Reorganisation of Synaptic Proteins in Alzheimer's Disease

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Altered synaptic plasticity at hippocampal CA1-CA3 synapses in Alzheimer's disease: integration of amyloid precursor protein intracellular domain and amyloid beta effects into computational models

Nanoarchitecture of CaV2.1 channels and GABAB receptors in the mouse hippocampus: Impact of APP/PS1 pathology

Selective disruption of synaptic NMDA receptors of the hippocampal trisynaptic circuit in Aβ pathology

Age-Dependent Shift of AMPA Receptors From Synapses to Intracellular Compartments in Alzheimer's Disease: Immunocytochemical Analysis of the CA1 Hippocampal Region in APP/PS1 Transgenic Mouse Model

Discrepancy of synaptic and microtubular protein phosphorylation in the hippocampus of APP/PS1 and MAPT×P301S transgenic mice at the early stage of Alzheimer's disease

Deregulated Local Protein Synthesis in the Brain Synaptosomes of a Mouse Model for Alzheimer’s Disease

Nanoscale organization is changed in native, surface AMPARs by mouse brain region and tauopathy

Tripartite Relationship Among Synaptic, Amyloid, and Tau Proteins: An In Vivo and Postmortem Study

Age-dependent alterations in the presynaptic active zone in a Drosophila model of Alzheimer's disease.

Computational investigation of Amyloid-β-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer’s disease

Early Disruption of Synaptic Function, Impairment of Plasticity, and Decreased of Cortical Circuit Connectivity in an Alzheimer’S Mouse Model of Amyloid Deposition

Oligomeric Aβ-induced Synaptic Dysfunction in Alzheimer’s Disease

Alterations in the axon initial segment plasticity is involved in early pathogenesis in Alzheimer's disease

Dysregulation of Neuropeptide and Tau Peptide Signatures in Human Alzheimer's Disease Brain

Pre-symptomatic synaptic dysfunction and longitudinal decay of hippocampal synaptic function in APPPS1 mouse model of Alzheimer's disease is sex-independent

Abnormal Dendritic Calcium Activity and Synaptic Depotentiation Occur Early in a Mouse Model of Alzheimer’s Disease

Astrocytic GluN2A and GluN2B Oppose the Synaptotoxic Effects of Amyloid-β1-40 in Hippocampal Cells.

Early-stage Reduction of the Dendritic Complexity in Basolateral Amygdala of a Transgenic Mouse Model of Alzheimer's Disease

Targeting Synaptic Pathology in Alzheimer’s Disease